Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Trimetazidine dihydrochloride manufacturers

8 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

8 products found

trimetazidine dihydrochloride

Tablets 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120
This globally competitive organization specializes in formulating a wide range of medications and exports to over 40 countries. Their state-of-the-art manufacturing facilities are strategically located across three cities, adhering to stringent regulatory standards like those set by the EU, UK, and UNICEF. They produce diverse dosage forms including tablets, capsules, creams, ointments, gels, and sterile formulations such as lyophilized products and prefilled syringes. Key therapy areas include complex generics, orphan drugs, and treatments for neglected tropical diseases. The company holds GMP certifications and possesses product patents, emphasizing their commitment to quality and innovation. They actively participate in global initiatives, providing emergency stockpiles for coronavirus treatments and partnering with organizations to address the healthcare needs of Palestinian refugees.

Manufacturer usually replies in 1 days

trimetazidine dihydrochloride

Tablets, extended release (ER) 35mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
Manufacturer #557
This organization is a multinational pharmaceutical company dedicated to providing affordable healthcare globally. They offer over 1,500 products across various therapeutic areas including HIV/AIDS, making significant contributions to accessibility in emerging markets like India, South Africa, and the U.S. Their product portfolio encompasses over 50 dosage forms, ranging from prescription medications and OTC drugs to potentially medical devices and supplements. They prioritize GMP certifications and hold patents for key products. Their commitment to affordability and inclusiveness has earned them recognition as a leader in global health initiatives.

Manufacturer usually replies in 27 days

trimetazidine dihydrochloride

Tablets, sustained release (SR) 20 mg, 35 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18285
The company is a pharmaceutical manufacturer focused on maintaining high-quality standards as a key competitive advantage, demonstrated by its ISO 9001:2015 accreditation and frequent quality audits. With a diverse product portfolio that spans therapeutic areas such as cardiology, diabetology, gynecology, neuro-psychiatry, orthopedics, and dermatology, the company is recognized for several top-performing brands in the Indian pharmaceutical market. Emphasizing practical application of research, the company actively participates in medical conferences, reflecting its commitment to ongoing professional development and engagement within the healthcare community.

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible